2020 annual financial data
Amylyx Pharmaceuticals 2020 Net income growth
Direct answer
Net income growth was -185.37%.
Operating income was -39,005,000 USD and net income was -42,280,000 USD.
Operating cash flow was -36,697,000 USD.
Get free Amylyx Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 650,000 USD
- Operating income
- -39,005,000 USD
- Net income
- -42,280,000 USD
- Operating cash flow
- -36,697,000 USD